AstraZeneca’s new R&D Centre and Alexion HQ in Cambridge, Massachusetts
Move brings together AstraZeneca and Alexion colleagues in a purpose-built facility in Kendall Square, Cambridge, MA, a world-leading life sciences hub
Move brings together AstraZeneca and Alexion colleagues in a purpose-built facility in Kendall Square, Cambridge, MA, a world-leading life sciences hub
CLNK is a biotechnology research and development company that utilizes umbilical cord blood as the raw material to develop innovative, allogeneic, off-the-shelf, cell based therapeutic products
It affects up to 10 per cent of women of reproductive age around the world
For over a decade, AstraZeneca and Plan India’s Young Health Program have been generating awareness and identifying sustainable solutions to influence the behaviour of youths against Non-Communicable Diseases
It is expanding the diagnostics business footprint in North East India
South Carolina’s largest health system adopts Philips software solutions for patient monitoring and enterprise imaging, helping to drive interoperability and data analytics, and deliver on Quadruple Aim
Approval based on groundbreaking Phase 3 EXPLORER-HCM trial demonstrating benefit in patients receiving Camzyos versus placebo
The procedure, named 'Shetty Test' after its creator, could change the way suspected fractures are treated
Glenmark Pharmaceuticals won Innovation of the Year award
Danish National Genome Center partners with Lifebit to deliver nationwide personalised medicine
Subscribe To Our Newsletter & Stay Updated